Injectable Birth Control Study
The Women’s Health Clinical Research Center at University of Pennsylvania is currently recruiting healthy women who have regular periods for a research study of an investigational injectable birth control. "Investigational" means that it is still being studied and has not been approved by the US FDA. This study will look at a new formulation of an existing kind of birth control. Women in the study will get one injection of the drug under the skin, and then come back to the clinic multiple times for blood tests, examinations and interviews.
Each woman will be in the study for about 13 months. This will include about one month of tests before the injection and then follow-up for at least 12 months after the injection. ut some women may be followed for as long as 18 months after the injection.
If you are interested in participating in the study you must be at low risk of becoming pregnant during, including: abstinent (not having intercourse), sterilized (tubes tied) or using a non-hormonal IUD; in a same-sex partnership; or in a partnership with a man who has had a vasectomy.
Participation in this study involves:
-
frequent site visits
-
physical and breast exams
-
blood tests
-
use of an investigational birth control injection
Qualified participants:
-
healthy, premenopausal women
-
have regular menstrual periods
-
18 to 40 years of age
-
low risk of becoming pregnant
-
does not have desire to become pregnant in the subsequent 36 months
Qualified participants will receive:
-
Medical exams
-
Compensation for time and travel ($65-$150 per completed visit)
To view the informed consent document for the study, click here (add link for informed consent)
If you are interested in seeing if you qualify for this study, click here or call 215.662.7727
Principal Investigator:
Dr. Kurt Barnhart, MD MSCE
Sponsor:
Teva
Research Coordinators:
Andrea Morley
215.615.4202
andrea.morley@uphs.upenn.edu
Simmone Henderson
215.615.5162
Simmone.henderson@uphs.upenn.edu